Amaze Holdings (AMZE) Completes The Food Channel Acquisition; Plans Platform Revamp for Culinary Creators — Nov 12, 2025

Amaze Holdings (AMZE) Soars on Q3 2025 Earnings as Revenue Jumps 1,884% and Creator-Commerce Strategy Accelerates

Published: November 14, 2025 Amaze Holdings, Inc. (NYSE American: AMZE) lit up the micro-cap tech screens on Friday after reporting third-quarter 2025 results showing a 1,884% year‑over‑year revenue surge and outlining an aggressive path to profitability built around AI‑powered creator commerce. The stock spiked more than 50% intraday on extremely heavy volume as traders digested the numbers and a week of product and M&A announcements. Amaze Holdings, Inc.+2Benzinga+2 Q3 2025: Revenue explodes, losses widen In an earnings release issued at 8:30 a.m. ET, Amaze reported Q3 2025 net revenue of $1.25 million, up from about $60,000 in the same quarter
Warner Bros Discovery Stock Skyrockets on $60B Takeover Rumors

Warner Bros. Discovery (WBD) Stock Climbs as Paramount, Comcast and Netflix Line Up Bids in High‑Stakes Auction – November 14, 2025

Warner Bros. Discovery, Inc. (NASDAQ: WBD) moved back into the spotlight on Friday, November 14, 2025, as a potential sale of all or part of the media giant appeared to crystallize into a three‑way contest between Paramount Skydance, Comcast and Netflix. The growing prospect of a bidding war sent WBD shares higher and intensified scrutiny of the company’s strategy, leadership and balance sheet. TradingView+3Sports Business Journal+3The Wall Street Journal+3 At the same time, new regulatory and governance angles emerged: a prominent U.S. lawmaker raised antitrust concerns about a possible Netflix deal, and Warner Bros. Discovery quietly rewrote CEO David Zaslav’s
Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

Cypherpunk Technologies (CYPH) Soars After Zcash Pivot: What Investors Need to Know on November 14, 2025

Updated: November 14, 2025Ticker: Nasdaq: CYPH Key Takeaways CYPH Stock Price Today: A Wild Debut for a Crypto–Biotech Hybrid Cypherpunk Technologies Inc. (CYPH) is having one of the most turbulent first weeks any newly rebranded small‑cap has seen in 2025. By early afternoon on November 14, multiple real‑time feeds showed CYPH trading a little above $3 per share, up roughly 70–85% on the day from Thursday’s close of about $1.76. MarketWatch+2Valley City Times-Record+2 At the same time, the stock has whipsawed dramatically: In short: CYPH is behaving more like a meme‑crypto than a traditional biotech, with intraday swings exceeding 100
Datavault AI (DVLT) Stock Skyrockets on AI Frenzy – Key Facts & Future Outlook

Datavault AI (DVLT) Sets Q3 2025 Earnings Date as Stablecoin Strategy and Meme Coin Dividend Energize Stock

November 14, 2025 Datavault AI Inc. (NASDAQ: DVLT) is back in the market spotlight today after confirming the date of its next earnings release, rolling out a fresh investor-focused “Datavault Insights” editorial, and showcasing its CEO on Schwab Network to talk stablecoins and the broader market outlook.Datavault AI Inc.+2FinancialContent+2 At the same time, DVLT stock is trading sharply higher in Friday action, hovering in the mid‑$1.70s and posting a double‑digit intraday gain on heavy volume, within a 52‑week range of roughly $0.25 to $4.10.Kraken+2Yahoo Finance+2 Below is a breakdown of everything Datavault AI investors need to know today, 14 November
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Merck’s $9.2 Billion Bid Sends Cidara Therapeutics (CDTX) Soaring 105% on November 14, 2025

Cidara Therapeutics, Inc. (NASDAQ: CDTX) is at the center of Wall Street’s attention today after Merck & Co., Inc. (NYSE: MRK) agreed to acquire the San Diego–based biotech in a cash deal valued at approximately $9.2 billion, sending CDTX shares more than 100% higher in a single session. Reuters+1 Below is a detailed look at today’s news (14 November 2025), the science behind Cidara’s lead flu-prevention asset CD388, the stock market reaction, and the wave of shareholder-law-firm investigations that emerged within hours of the announcement. Merck to Acquire Cidara for $221.50 Per Share in Cash Merck and Cidara announced this
Alibaba Stock Soars on AI Frenzy – Can the Rally Last?

Alibaba (BABA) Stock Today, November 14, 2025: Price Slips as AI Push, Blockchain Deals and White House Memo Collide

Alibaba Group Holding (NYSE: BABA) is having a volatile session on Friday, November 14, 2025, as the stock digests a heavy mix of bullish AI and fintech announcements, a new US national‑security headline, and earnings and Singles’ Day uncertainty. Alibaba (BABA) stock price today As of the latest trade at 18:24:06 UTC on November 14, 2025, Alibaba’s US‑listed ADRs were: Even after today’s pullback, BABA remains one of 2025’s standout China tech names: different data providers put its year‑to‑date gain at roughly 88–96%, reflecting a near‑doubling of the share price this year. Yahoo Finance+1 On valuation, recent snapshots from MarketBeat
JPMorgan Hit With Record €45m BaFin AML Fine as It Bets Big on Berlin Chase Launch

JPMorgan Hit With Record €45m BaFin AML Fine as It Bets Big on Berlin Chase Launch

Germany’s financial watchdog BaFin has slammed JPMorgan SE with a record €45 million (about $52 million) penalty for anti–money laundering (AML) failures, just as the U.S. banking giant opens a new Berlin hub to launch its Chase digital retail bank and steps up expansion across Europe and Türkiye.Reuters+2Reuters+2 The clash of timelines — a landmark enforcement action announced on 6 November and an ambitious retail push in Europe’s largest economy unveiled days later — sets up one of the most closely watched tests of how far global banks can grow while staying on the right side of increasingly tough regulators.
14 November 2025
Agentic AI Hits an Inflection Point: Enterprise ROI, Software Winners and New Risks – November 14, 2025

Agentic AI Hits an Inflection Point: Enterprise ROI, Software Winners and New Risks – November 14, 2025

Agentic AI is moving from hype to hard numbers. On November 14, 2025, new research and deals show where AI agents are delivering ROI — and where risks are rising. Agentic AI Is No Longer Just Hype As of November 14, 2025, “agentic AI” – AI systems that pursue goals autonomously across tools and data – has clearly become the enterprise buzzword of the year. But today’s news flow suggests it’s now more than branding: some companies are finally seeing returns, while others scramble to rebuild their tech stacks and risk controls around AI agents. Three influential pieces set the
CoreWeave (CRWV) Stock Extends Sell-Off After Guidance Cut: Key Updates for November 14, 2025

CoreWeave (CRWV) Stock Extends Sell-Off After Guidance Cut: Key Updates for November 14, 2025

CoreWeave, Inc. (NASDAQ: CRWV) — the Nvidia‑backed AI cloud infrastructure provider that went public in March — is back in the spotlight today as its stock continues to slide despite eye‑popping growth and a pipeline full of multi‑billion‑dollar AI deals. As of late morning trading on Friday, Nov. 14, CRWV was changing hands around $77.49, down from a previous close of $78.34 and well below its 52‑week high of $187.00. That puts CoreWeave roughly 60% beneath its peak and values the company at about $36.9 billion. Google+1 Pre‑market, shares traded even lower at about $75.90, adding to an 8% drop
14 November 2025
BigBear.ai (BBAI) Stock Today: Cantor Hikes Target to $7 as Options Volume Surges – November 14, 2025

BigBear.ai (BBAI) Stock Today: Cantor Hikes Target to $7 as Options Volume Surges – November 14, 2025

As of Friday, November 14, 2025, BigBear.ai Holdings, Inc. (NYSE: BBAI) is cooling slightly after a blistering post‑earnings rally, but Wall Street attention is still locked on the defense‑focused AI name. The day’s BigBear.ai story is being shaped by three fresh developments: Below is a full rundown of where the stock stands today and how the latest news fits into the bigger BigBear.ai story. Where BigBear.ai Stock Stands on November 14, 2025 BigBear.ai shares are trading around $6.28 this afternoon, down only a few cents on the day after a wild week that included double‑digit intraday swings. Today’s intraday range
14 November 2025
Pfizer Completes $10 Billion Metsera (MTSR) Buyout as Nasdaq Delists Stock Today

Pfizer Completes $10 Billion Metsera (MTSR) Buyout as Nasdaq Delists Stock Today

Metsera Inc. (NASDAQ: MTSR) stops trading today, November 14, 2025, as Pfizer closes its up to $10 billion obesity-drug acquisition. Here’s what Metsera shareholders and obesity-market investors need to know about the deal terms, CVR, delisting, and future milestones. Date: November 14, 2025Ticker: MTSR (Metsera, Inc.) – now being delisted On Friday, November 14, 2025, Metsera, Inc. officially disappears from the Nasdaq tape. Trading in Metsera (NASDAQ: MTSR) has been suspended after Pfizer completed its acquisition of the obesity-focused biotech in a deal valued at up to $10 billion, capping one of the fiercest pharma bidding wars of the year.
Rigetti Computing (RGTI) Stock Faces Quantum Reality Check: Cramer’s “Sell Half” Call, Bubble Fears and Q3 Fallout – 14 November 2025

Rigetti Computing (RGTI) Stock Faces Quantum Reality Check: Cramer’s “Sell Half” Call, Bubble Fears and Q3 Fallout – 14 November 2025

Quantum darling Rigetti Computing, Inc. (NASDAQ: RGTI) is having one of the wildest years on Wall Street – and today, 14 November 2025, the story took another sharp turn. After a nearly 2,000% surge over the past 12 months, Rigetti’s share price has now collapsed about 60% from its mid‑October peak, as a wave of new headlines hits the stock, sector-wide bubble fears grow, and high‑profile voices urge caution. Verified Investing+1 Below is a structured roundup of all the key Rigetti news pieces dated 14 November 2025, plus the context investors need around Q3 earnings, valuation, and the broader quantum
14 November 2025
Intel Stock Today (INTC): Oregon Layoffs, AI Shake‑Up and Wall Street Re‑Think — 14 November 2025

Intel Stock Today (INTC): Oregon Layoffs, AI Shake‑Up and Wall Street Re‑Think — 14 November 2025

Intel Corporation (NASDAQ: INTC) is back in the spotlight today as fresh job cuts in Oregon, an AI leadership reshuffle, and a wave of new institutional filings collide with lingering concerns about its artificial intelligence strategy and profitability. Intel Stock Today: INTC Pauses After 5% Slide After a sharp sell‑off on Thursday, Intel stock is trading around $35.77 on Friday afternoon, down about 0.4% on the day. That leaves shares just below Thursday’s close of $35.91, when the stock dropped roughly 5.2% in a single session.MarketBeat According to MarketBeat data, the recent slump comes after a strong 2025 rally that
14 November 2025
Tripadvisor (TRIP) Stock Edges Higher as Mizuho Upgrade Backs Cost Cuts, Viator Merger and AI Pivot – November 14, 2025

Tripadvisor (TRIP) Stock Edges Higher as Mizuho Upgrade Backs Cost Cuts, Viator Merger and AI Pivot – November 14, 2025

Tripadvisor, Inc. (NASDAQ: TRIP) returned to investors’ good graces on Friday after Mizuho upgraded the online travel company and lifted its price target, signaling Wall Street is starting to warm to an aggressive restructuring that includes layoffs, a Viator merger and a deeper bet on AI-powered travel experiences. Investing.com+1 As of mid‑day Friday, Tripadvisor shares were trading around $15.00, up roughly 1.5% from Thursday’s close at $14.78, though still well below their 52‑week high of $20.16. Investing.com+1 The bounce follows a bruising 6.75% slide on Thursday, when the stock sold off with the broader market despite recently reporting better‑than‑expected Q3
Dollar General and Kathy Ireland Launch $50,000 ‘Reading Revolution’ at Andrew Jackson Elementary

Dollar General and Kathy Ireland Launch $50,000 ‘Reading Revolution’ at Andrew Jackson Elementary

Dollar General and supermodel-turned-business leader Kathy Ireland are turning the spotlight on student literacy this week with a surprise $50,000 “Reading Revolution” donation and hundreds of cozy reading-themed gifts for Andrew Jackson Elementary School in Old Hickory, Tennessee. The initiative, highlighted today in new coverage from Drug Store News, is part of Dollar General’s long-running Reading Revolution program and its broader Here For What Matters community platform.Drug Store News+1 Inside Dollar General’s $50,000 Reading Revolution Surprise At a school event earlier this week, Dollar General presented Andrew Jackson Elementary with a $50,000 Reading Revolution grant — funds that school leaders
14 November 2025
Milestone Scientific (MLSS) Soars on Q3 2025 Earnings, Cost Cuts and Board Shake-Up – Latest for 14 November 2025

Milestone Scientific (MLSS) Soars on Q3 2025 Earnings, Cost Cuts and Board Shake-Up – Latest for 14 November 2025

Milestone Scientific Inc. (NYSE American: MLSS) is back on traders’ radar today after a sharp after‑hours spike, strong pre‑market performance and fresh Q3 2025 numbers that show progress on costs but lingering listing‑compliance and funding risks. Key headlines on Milestone Scientific today As of Friday, 14 November 2025, these are the main developments around Milestone Scientific: MLSS stock today: big moves, tiny price According to real‑time quote data, Milestone Scientific shares are changing hands around $0.37 this afternoon, down slightly on the day but still well above where they traded before the earnings release. Intraday, the stock has: Recent performance
14 November 2025
Trump-Backed American Bitcoin Corp (ABTC) Q3 2025 Earnings: Revenue Jumps 453% as BTC Hoard Tops 4,000, But Stock Whipsaws on Bitcoin Crash

Trump-Backed American Bitcoin Corp (ABTC) Q3 2025 Earnings: Revenue Jumps 453% as BTC Hoard Tops 4,000, But Stock Whipsaws on Bitcoin Crash

Trump-linked Bitcoin miner American Bitcoin Corp (Nasdaq: ABTC) has just posted its first quarterly profit as a public company, with Q3 2025 revenue surging to $64.2 million and its Bitcoin reserve climbing above 4,000 BTC. Yet despite the blockbuster numbers, ABTC shares swung sharply lower in early trading as Bitcoin itself tumbled below $95,000 in a violent crypto sell-off. PR Newswire+2Finviz+2 Key takeaways Q3 2025: Revenue explosion and a clean swing to profit American Bitcoin’s Q3 2025 report, released before the opening bell, marks a dramatic scaling-up in both size and profitability. PR Newswire+1 According to the company’s Form 10‑Q
Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025

Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025

On Friday, November 14, 2025, Cytek Biosciences, Inc. (NASDAQ: CTKB) is trading sharply higher, extending a strong two‑week run helped by fresh industry recognition, product awards and steady (if modest) earnings growth. As of the latest trade this afternoon, CTKB is changing hands around $4.99, up roughly 9% intraday, with the stock appearing on Nasdaq’s list of notable movers even as the broader U.S. market trades lower.Benzinga Below is a breakdown of all the key Cytek‑related news impacting CTKB today, November 14, 2025, plus the most important headlines from the past few days that are driving sentiment. 1. What’s New
14 November 2025
Scholar Rock (NASDAQ: SRRK) Soars on FDA Progress, $200M ATM and Q3 2025 Earnings – November 14, 2025 Update

Scholar Rock (NASDAQ: SRRK) Soars on FDA Progress, $200M ATM and Q3 2025 Earnings – November 14, 2025 Update

Scholar Rock Holding Corporation (NASDAQ: SRRK) is back in the spotlight as its stock jumps more than 25% on the day after a pivotal FDA meeting, fresh Q3 2025 financial results, and the launch of a new $200 million at-the-market (ATM) stock offering. SRRK stock jumps over 25% after FDA “constructive” meeting Scholar Rock shares are surging today. As of the latest trade, SRRK is changing hands around $37.98, up roughly 26% on the session, after touching an intraday high above $39. Daily trading volume has climbed to about 2.75 million shares, well above normal levels. The move is being
StubHub Holdings (STUB) Crashes Over 25% After First Earnings as Public Company – What’s Really Going On?

StubHub Holdings (STUB) Crashes Over 25% After First Earnings as Public Company – What’s Really Going On?

StubHub Holdings (NYSE: STUB) shares plunged more than 25% today after the ticket marketplace’s first earnings report as a public company, a deep GAAP loss and a wave of Wall Street price‑target cuts. Here’s what the Q3 2025 numbers and analyst reactions mean for investors. Key Takeaways StubHub’s First Quarter as a Public Company: Growth on the Platform, Noise in the P&L StubHub’s Q3 2025 report is its first full earnings release since going public on the NYSE in September. The headline numbers show a marketplace that’s still growing: On an adjusted basis, StubHub is clearly trending the right way:
14 November 2025

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop